TWST logo

Twist Bioscience (TWST) EBIT

annual EBIT:

-$208.14M-$4.68M(-2.30%)
September 30, 2024

Summary

  • As of today (June 22, 2025), TWST annual earnings before interest & taxes is -$208.14 million, with the most recent change of -$4.68 million (-2.30%) on September 30, 2024.
  • During the last 3 years, TWST annual EBIT has fallen by -$54.48 million (-35.45%).
  • TWST annual EBIT is now -380.22% below its all-time high of -$43.34 million, reached on September 30, 2016.

Performance

TWST EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

quarterly EBIT:

-$39.01M-$7.54M(-23.95%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST quarterly earnings before interest & taxes is -$39.01 million, with the most recent change of -$7.54 million (-23.95%) on March 31, 2025.
  • Over the past year, TWST quarterly EBIT has increased by +$6.14 million (+13.59%).
  • TWST quarterly EBIT is now -136.24% below its all-time high of -$16.51 million, reached on March 31, 2018.

Performance

TWST quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

TTM EBIT:

-$190.59M+$6.14M(+3.12%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TWST TTM earnings before interest & taxes is -$190.59 million, with the most recent change of +$6.14 million (+3.12%) on March 31, 2025.
  • Over the past year, TWST TTM EBIT has increased by +$686.00 thousand (+0.36%).
  • TWST TTM EBIT is now -1045.20% below its all-time high of -$16.64 million, reached on September 30, 2017.

Performance

TWST TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTWSTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TWST EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.3%+13.6%+0.4%
3 y3 years-35.5%+35.8%+4.7%
5 y5 years-96.2%-23.9%-31.3%

TWST EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.5%+8.8%-23.9%+54.3%at high+16.5%
5 y5-year-96.2%+8.8%-63.1%+54.3%-64.1%+16.5%
alltimeall time-380.2%+8.8%-136.2%+54.3%-1045.2%+16.5%

TWST EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$39.01M(+23.9%)
-$190.59M(-3.1%)
Dec 2024
-
-$31.47M(-9.4%)
-$196.72M(-5.5%)
Sep 2024
-$208.14M(+2.3%)
-$34.72M(-59.3%)
-$208.14M(-5.3%)
Jun 2024
-
-$85.38M(+89.1%)
-$219.88M(+15.0%)
Mar 2024
-
-$45.15M(+5.3%)
-$191.27M(-6.5%)
Dec 2023
-
-$42.89M(-7.7%)
-$204.60M(+0.6%)
Sep 2023
-$203.46M(-10.8%)
-$46.46M(-18.2%)
-$203.46M(-2.1%)
Jun 2023
-
-$56.77M(-2.9%)
-$207.79M(-1.8%)
Mar 2023
-
-$58.48M(+40.1%)
-$211.69M(-1.1%)
Dec 2022
-
-$41.75M(-17.8%)
-$214.00M(-6.2%)
Sep 2022
-$228.19M(+48.5%)
-$50.80M(-16.3%)
-$228.19M(+4.6%)
Jun 2022
-
-$60.67M(-0.2%)
-$218.21M(+9.2%)
Mar 2022
-
-$60.79M(+8.7%)
-$199.89M(+13.0%)
Dec 2021
-
-$55.94M(+37.1%)
-$176.87M(+15.1%)
Sep 2021
-$153.66M
-$40.82M(-3.6%)
-$153.66M(+12.4%)
Jun 2021
-
-$42.34M(+12.1%)
-$136.76M(+11.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$37.76M(+15.4%)
-$122.42M(+5.4%)
Dec 2020
-
-$32.74M(+36.9%)
-$116.15M(-16.3%)
Sep 2020
-$138.76M(+30.8%)
-$23.91M(-14.6%)
-$138.76M(-4.7%)
Jun 2020
-
-$28.00M(-11.1%)
-$145.63M(+0.3%)
Mar 2020
-
-$31.49M(-43.1%)
-$145.17M(+4.3%)
Dec 2019
-
-$55.35M(+79.8%)
-$139.19M(+31.2%)
Sep 2019
-$106.08M(+52.2%)
-$30.78M(+11.8%)
-$106.08M(+12.1%)
Jun 2019
-
-$27.54M(+8.0%)
-$94.64M(+12.2%)
Mar 2019
-
-$25.51M(+14.7%)
-$84.31M(+11.9%)
Dec 2018
-
-$22.25M(+15.0%)
-$75.32M(+8.1%)
Sep 2018
-$69.68M(+19.9%)
-$19.34M(+12.3%)
-$69.68M(+4.0%)
Jun 2018
-
-$17.22M(+4.3%)
-$66.98M(+34.6%)
Mar 2018
-
-$16.51M(-0.6%)
-$49.77M(+49.7%)
Dec 2017
-
-$16.61M(-0.2%)
-$33.25M(+99.8%)
Sep 2017
-$58.13M(+34.1%)
-$16.64M
-$16.64M
Sep 2016
-$43.34M
-
-

FAQ

  • What is Twist Bioscience annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Twist Bioscience?
  • What is Twist Bioscience annual EBIT year-on-year change?
  • What is Twist Bioscience quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Twist Bioscience?
  • What is Twist Bioscience quarterly EBIT year-on-year change?
  • What is Twist Bioscience TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Twist Bioscience?
  • What is Twist Bioscience TTM EBIT year-on-year change?

What is Twist Bioscience annual earnings before interest & taxes?

The current annual EBIT of TWST is -$208.14M

What is the all time high annual EBIT for Twist Bioscience?

Twist Bioscience all-time high annual earnings before interest & taxes is -$43.34M

What is Twist Bioscience annual EBIT year-on-year change?

Over the past year, TWST annual earnings before interest & taxes has changed by -$4.68M (-2.30%)

What is Twist Bioscience quarterly earnings before interest & taxes?

The current quarterly EBIT of TWST is -$39.01M

What is the all time high quarterly EBIT for Twist Bioscience?

Twist Bioscience all-time high quarterly earnings before interest & taxes is -$16.51M

What is Twist Bioscience quarterly EBIT year-on-year change?

Over the past year, TWST quarterly earnings before interest & taxes has changed by +$6.14M (+13.59%)

What is Twist Bioscience TTM earnings before interest & taxes?

The current TTM EBIT of TWST is -$190.59M

What is the all time high TTM EBIT for Twist Bioscience?

Twist Bioscience all-time high TTM earnings before interest & taxes is -$16.64M

What is Twist Bioscience TTM EBIT year-on-year change?

Over the past year, TWST TTM earnings before interest & taxes has changed by +$686.00K (+0.36%)
On this page